Harry Quandt

This inventor holds 12 USPTO granted patents and 9 published patent applications, plus 1 CIPO patent and 4 EPO patents. Top assignees: Endo Pharmaceuticals Solutions Inc., Braeburn Pharmaceuticals Bvba Sprl, Hydro Med Sciences, Inc.. Active years: 2002-2015.

USPTO Granted Patents = 12 (Patent Applications = 9)

% Patents Active = 58.3

CIPO Patents = 1

EPO Patents = 4 (Patent Applications = 9)

Average Co-Inventor Count = 2.4

ph-index = 6

Forward Citations = 149(Granted Patents)

Company Filing History:

10 out of 26

Endo Pharmaceuticals Solutions Inc.

patents

1 out of 3

Braeburn Pharmaceuticals Bvba Sprl

patents

1 out of 2

Hydro Med Sciences, Inc.

patents

Years Active: 2002-2015

Loading Chart...

12 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9120249 - Implant device release agents and methods of using same (2015-09-01),

2. 9078900 - Implantable device for the delivery of risperidone and methods of use thereof (2015-07-14),

3. 9072786 - Method of manufacturing an implantable device (2015-07-07),

4. 8784865 - Long term drug delivery devices with polyurethane-based polymers and their manufacture (2014-07-22),

5. 8475820 - Method of manufacturing an implantable device (2013-07-02),

6. 8460274 - Long term drug delivery devices with polyurethane-based polymers and their manufacture (2013-06-11),

7. 8383577 - Octreotide implant having a release agent (2013-02-26),

8. 8303977 - Long term drug delivery devices with polyurethane-based polymers and their manufacture (2012-11-06),

9. 8071537 - Implantable device for the sustained release of a polypeptide (2011-12-06),

10. 7960335 - Octreotide implant having a release agent and uses thereof (2011-06-14),

11. 7858110 - Long term drug delivery devices with polyurethane based polymers and their manufacture (2010-12-28),

12. 6361797 - Hydrogel compositions useful for the sustained release of macromolecules and methods of making same (2002-03-26),

Title: The Innovations of Harry Quandt

Introduction

Harry Quandt is a notable inventor based in Bensalem, PA (US), recognized for his contributions to the field of medical implant devices. With a total of 12 patents to his name, he has made significant advancements in the development of biocompatible and biostable drug delivery systems.

Latest Patents

Among his latest patents, one focuses on implant device release agents and methods of using the same. This invention involves medical implant devices made from a polymeric material and a release agent, where the release agent has a molecular weight (MW) of at least 1000. The release agent may include non-ionic surfactants such as Brij 35, polyoxyethylene(20)sorbitan trioleate, Tween 20, Tween 80, and vitamin E TPGS. Another significant patent is for an implantable device designed for the delivery of risperidone. This device utilizes a polyurethane-based polymer to deliver biologically active risperidone at a constant rate over an extended period, proving useful for both human and animal patients.

Career Highlights

Harry Quandt has worked with several prominent companies in the pharmaceutical industry, including Endo Pharmaceuticals Solutions Inc. and Braeburn Pharmaceuticals. His work has focused on creating innovative solutions that enhance the effectiveness and safety of medical treatments.

Collaborations

Throughout his career, Harry has collaborated with talented professionals such as Petr Kuzma and Stefanie Decker, contributing to the advancement of medical technology.

Conclusion

Harry Quandt's innovative work in the field of medical implants and drug delivery systems showcases his dedication to improving patient care through technology. His numerous patents reflect his commitment to advancing medical science and enhancing the quality of life for patients.